Content is free to use but usage restrictions apply. Please visit our FAQ for conditions of use. If you click download/embed, you acknowledge that you have read and will respect the terms of use.
German biotech firm BioNTech has never brought a vaccine to market before but it is now in pole position in the race to develop a jab that will end the coronavirus crisis